Osteonecrosis of the femoral head in a human immunodeficiency virus type 1-infected patient with lipodystrophy

Journal of the Formosan Medical Association

Volumn 101, Issue 3, 2002, Pages 210-213

  Tsai, Yu Chieh ^a   Liu, Chen Hua ^a   Liao, Chun Hsing ^a   Chen, Mao Yuan ^a   Hung, Chien Ching ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Avascular necrosis; Human immunodeficiency virus; Lipodystrophy; Osteonecrosis; Protease inhibitor

Indexed keywords

DICLOFENAC; EFAVIRENZ; INDINAVIR; LAMIVUDINE; NONSTEROID ANTIINFLAMMATORY AGENT; RITONAVIR; SAQUINAVIR; SIMVASTATIN; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; FEMUR HEAD NECROSIS; GASTROINTESTINAL HEMORRHAGE; HETEROSEXUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; LEG PAIN; LIPODYSTROPHY; MALE; OSTEOARTHRITIS; PATIENT MONITORING; PHYSICAL DISABILITY; PRURITUS; RADIOGRAPHY; SURVIVAL; TAIWAN;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMUR HEAD NECROSIS; HIV-1; HUMANS; LIPODYSTROPHY; MALE;

EID: 0036265160     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
2. Clinical spectrum, morbidity, and mortality of acquired immunodeficiency syndrome in Taiwan: A 5-year prospective study
3. A syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance in patients receiving HIV protease inhibitors
4. Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy
5. Osteonecrosis of the femoral head in patients receiving HIV protease inhibitors
6. Osteonecrosis in HIV: A case-control study
7. Avascular necrosis of bone in patients with human immunodeficiency virus infection: Report of 6 cases and review of the literature
8. Osteonecrosis complicating highly active antiretroviral therapy in patients infected with human immunodeficiency virus
9. Indinavir inhibits bone formation while ritonavir inhibits osteoclast differentiation and function